The influence of triglycerides on small dense low‐density lipoprotein cholesterol levels is attenuated in low low‐density lipoprotein‐cholesterol range: Implications for the negative results of the PROMINENT trial

The Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) trial failed to show the preventive effects of pemafibrate, a triglyceride (TG)‐lowering drug, on atherosclerotic cardiovascular disease in patients with type 2 diabetes and dyslipidemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirano, Tsutomu, Ito, Yasuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286789/
https://www.ncbi.nlm.nih.gov/pubmed/37016542
http://dx.doi.org/10.1111/jdi.14013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286789/
https://www.ncbi.nlm.nih.gov/pubmed/37016542
http://dx.doi.org/10.1111/jdi.14013

Ejemplares similares